Core & Trust
Provider Right to Respond
How a provider disputes something we published
Any provider named on this site can contest a fact, a figure or a score. We will publish a correction if the evidence supports it and publish the dispute if it does not. What a provider cannot do is approve, edit or preview our conclusions.
Any provider named on this site can contest a fact, a figure or a score. We will publish a correction if the evidence supports it and publish the dispute if it does not. What a provider cannot do is approve, edit or preview our conclusions.
Show this figure as a table
| Step | Stage | What happens |
|---|---|---|
| 1 | Someone raises it | A reader, a provider or an editor flags the issue. |
| 2 | It is assessed against the ledger | We reopen the source and the capture date. |
| 3 | A decision is recorded | Correct, clarify, or explain why the original stands. |
| 4 | The change is published and dated | Old figures stay visible in the log. |
| Area | Commitment | How you can check it |
|---|---|---|
| Every figure | Carries a source and a capture date | Open the provenance stamp beside it |
| Every clinical claim | Traced to a primary source | Follow the citation, not our summary |
| Every score | Computed from published inputs | Read the raw inputs on the provider page |
| Every correction | Dated and permanent | Read the corrections log |
| Every medical review | Dated on the page | Read “Last medically reviewed” in the byline |
A dash means no figure held. How we grade evidence.
What this policy covers
Any provider, pharmacy or manufacturer named on this site can challenge what we say about it: a price, a date, a description of its service, a pharmacy name, a regulatory statement, or a score under the v4.1 methodology.
This matters to readers for two reasons. It is one of the main ways errors about providers get caught. And it sets limits on what a provider can do. A provider cannot approve, edit or preview a page before it publishes. It cannot buy a better score or a higher position. Compensation never changes our methodology, rankings or the prices we report.
The policy does not cover requests to remove accurate information, to move up without new evidence, or to use our name in a provider's marketing.
How we apply it
- Submission. The provider sends its objection through the contact page: the page, the specific claim, and its evidence. Evidence we can check ourselves counts most: a dated page on the provider's own site, a pharmacy licence record, a published price.
- Review. The editor responsible for the page reopens our source and the provider's. Prices go to the pricing researcher. Clinical claims go to the medical reviewers.
- Decision. If the evidence supports the provider, we correct the page and log it on the corrections log. If a score input changes, the score is recomputed under the published rubric. If the evidence does not support the provider, the original stands and we publish the provider's response alongside it.
- Record. The outcome is dated either way.
A price a provider tells us privately is labelled provider-reported until we can read it on the provider's own page.
How to hold us to it
If you are a provider and think we have not followed this process, write again through the contact page. Say which step you think failed and what you sent.
Readers can check the process too. Resolved disputes that changed a page appear on the corrections log with the date, the previous wording and the reason. Disputes we did not accept are published with the provider's response next to the original claim. The log on this page lists dated events as they happen.
We have not published a fixed response time, so we will not promise one here.
The fastest route to a change is usually evidence rather than argument: publish an all-in price at a maintenance dose, name the fulfilling pharmacy, and tell us where to read both.
Log
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How a dispute actually proceeds
Step one. Send the page URL, the specific claim you dispute, and what you believe the correct position is. General objections to tone or conclusion are noted; specific factual disputes are investigated.
Step two. We reopen our own source. If we captured a figure from your published page on a stated date, we check whether that page has since changed — which happens often, and is a legitimate reason for a discrepancy rather than an error on either side.
Step three. If the evidence supports your position, we correct and log it publicly with the date, the previous wording and the reason. If it does not, we publish your response alongside the original claim.
The two fastest routes to a change
Publish your all-in price at a maintenance dose, including every required fee. A company that does this can be compared accurately, which is generally to the advantage of companies with nothing to hide.
Name your fulfilling pharmacy and its registration class. No provider in our dataset has done this, so every pharmacy relationship on this site is labelled unverified. That label disappears the day it is answered.
What a provider cannot do
Preview coverage before publication. Approve or edit our conclusions. Have an accurate finding removed. Or obtain a scoring adjustment in exchange for cooperation, data, or anything else.
Those limits apply to every company without exception, and stating them plainly is what makes the right of response meaningful rather than decorative.
Related on this site
- Tirzepatide Ranked: Evidence, Prices, Providers & ToolsCore & Trust
- About Tirzepatide RankedCore & Trust
- Editorial StandardsCore & Trust
- Provider Ranking MethodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Corrections and Update LogCore & Trust
- Contact the Editorial TeamCore & Trust
- Conflicts of Interest PolicyCore & Trust
- AI Use PolicyCore & Trust
Related coverage
- Tirzepatide for Type 2 Diabetes
- Compounded tirzepatide price index
- What you pay at a maintenance dose
- GLP-1s in Adolescents: What the Evidence Supports and What It Does Not
- GLP-1s and Knee Osteoarthritis: Real Pain Reduction, Unsettled Mechanism
- Muscle Loss on GLP-1s: What the 2026 Body-Composition Data Shows
- GLP-1 Weight Loss and Muscle Preservation
- GLP-1s After 65: The Risks That Differ From Younger Patients
- GLP-1s and PCOS: Promising Signals, Thin Evidence, and a Fertility Warning
Tirzepatide Ranked. “Provider Right to Respond.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/right-to-respond/
Quote the capture date beside a figure, not the date you read this page. Why.